These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7520315)

  • 21. Performance of rapid HIV-1/HIV-2 INSTI on plasma and capillary blood for serological diagnosis of non B subtypes and circulating recombinant forms of HIV-1 in Gabon.
    Ndjoyi-Mbiguino A; Nzengui Nzengui GF; Robin L; M'Boyis Kamdem H; Bélec L
    Med Mal Infect; 2015 Aug; 45(8):339-40. PubMed ID: 26159380
    [No Abstract]   [Full Text] [Related]  

  • 22. [Retrovirus and blood transfusion].
    Barrera JM; Ercilla MG; Gil BC
    Sangre (Barc); 1993 Jun; 38(3):187-92. PubMed ID: 8105545
    [No Abstract]   [Full Text] [Related]  

  • 23. Relevance of the reactivity of HIV 1 positive sera with synthetic peptides for understanding antigenic differences between circulating strains.
    Cernescu C; Ruţă SM
    Rev Roum Virol; 1993; 44(3-4):175-86. PubMed ID: 7826868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization and challenge of chimpanzees with HIV-1.
    Fultz PN
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1517-9. PubMed ID: 1466994
    [No Abstract]   [Full Text] [Related]  

  • 25. [New aspects in HIV diagnosis].
    Gürtler L; Eberle J; Bader L; Deinhardt F
    Internist (Berl); 1990 Sep; 31(9):587-92. PubMed ID: 2242983
    [No Abstract]   [Full Text] [Related]  

  • 26. [Current status of HIV serology].
    Eberle J; Gürtler L; Deinhardt F
    Verh Dtsch Ges Inn Med; 1989; 95():406-9. PubMed ID: 2690511
    [No Abstract]   [Full Text] [Related]  

  • 27. Artificial antigens for HIV vaccine design.
    Expert Rev Vaccines; 2007 Jun; 6(3):301. PubMed ID: 17542744
    [No Abstract]   [Full Text] [Related]  

  • 28. [Detection of HIV infection by serologic procedures].
    Schmidt BL
    Z Hautkr; 1990 Jul; 65(7):633-4, 637-9. PubMed ID: 2205060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immune response to HIV: implications for vaccine development.
    Bolognesi DP
    Semin Immunol; 1993 Jun; 5(3):203-14. PubMed ID: 8347841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human versus HIV: round 2 defeat in AIDS vaccine development.
    Lu S
    Expert Rev Vaccines; 2008 Mar; 7(2):151-3. PubMed ID: 18324884
    [No Abstract]   [Full Text] [Related]  

  • 31. The antibody response in HIV-1 infection.
    Burton DR; Montefiori DC
    AIDS; 1997; 11 Suppl A():S87-98. PubMed ID: 9451972
    [No Abstract]   [Full Text] [Related]  

  • 32. Seroreactivity of analogous antigenic epitopes in glycoprotein 120 expressed in HIV-1 subtypes A, B, C, and D.
    Pestano GA; Hosford KS; Spira AI; Riley J; Xie JM; Sewankambo N; Brown L; Ho DD; Boto WM
    AIDS Res Hum Retroviruses; 1995 May; 11(5):589-96. PubMed ID: 7576915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV/AIDS. HLA leaves its footprints on HIV.
    McMichael A; Klenerman P
    Science; 2002 May; 296(5572):1410-1. PubMed ID: 12029119
    [No Abstract]   [Full Text] [Related]  

  • 34. Surveillance for variant strains of HIV: subtype G and group O HIV-1.
    Sullivan PS; Do AN; Robbins K; Kalish M; Subbarao S; Pieniazek D; Schable C; Afaq G; Markowitz J; Myers R; Joseph JM; Benjamin G
    JAMA; 1997 Jul 23-30; 278(4):292. PubMed ID: 9228433
    [No Abstract]   [Full Text] [Related]  

  • 35. Genotypic and phenotypic variation of HIV-1: impact on AIDS pathogenesis and vaccination.
    Wolfs TF; Nara PL; Goudsmit J
    Chem Immunol; 1993; 56():1-33. PubMed ID: 8383980
    [No Abstract]   [Full Text] [Related]  

  • 36. HIV-2 infection and HIV-1/HIV-2 dual reactivity in patients with and without AIDS-related symptoms in Gabon.
    Tevi-Benissan C; Okome M; Makuwa M; Nkoume MN; Lansoud-Soukate J; Georges A; Georges-Courbot MC; Belec L
    Emerg Infect Dis; 1998; 4(1):130-1. PubMed ID: 9452410
    [No Abstract]   [Full Text] [Related]  

  • 37. [The dynamics of HIV variation].
    Wain-Hobson S
    Internist (Berl); 1994 Oct; 35(10):893-5. PubMed ID: 8002222
    [No Abstract]   [Full Text] [Related]  

  • 38. [Reactivity differences between serums of patients infected with HIV-2 and HIV-1 antigens according to the patients' geographic origin].
    Simon F; Loussert-Ajaka I; Collin G; Gamba E; Powell-Smith A; Gadelle S; Brun-Vézinet F
    Sante; 1994; 4(1):27-31. PubMed ID: 8162361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New HIV-1 subtype in Switzerland.
    Joller-Jemelka HJ; Sandoz PF; Glauser A; Joller PW
    Lancet; 1994 Jul; 344(8917):270-1. PubMed ID: 7913188
    [No Abstract]   [Full Text] [Related]  

  • 40. India, Japan launch HIV vaccines to match local strains.
    Chou IH; Jayaraman KS
    Nat Med; 2004 Mar; 10(3):215. PubMed ID: 14991027
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.